SILVER SPRING, Md. — The Food and Drug Administration has approved Perrigo’s generic of Hill Dermaceuticals’ DermOtic Oil (fluocinolone acetonide oil, 0.01%) ear drops. The drug is indicated to treat chronic eczematous external otitis in adults and children ages 2 years and older.
DermOtic Oil had annual U.S. sales of roughly $26 million.
“Upon launch, this will be our fifth new product launched in 2017. These launches include the generic versions of Axiron, Derma-Smoothe/FS Scalp Oil, Derma-Smoothe/FS Body Oil and Hycodan,” Perrigo EVP and president Rx pharmaceuticals John Wesolowski said. “Bringing these new products to market illustrates the Rx team's commitment to providing affordable treatment options for patients in important extended topical categories.”